Trial intelligence / Profile preview

Anakinra in heart failure with advanced CKD

NCT03062176Phase 2Withdrawn

Sponsor
Virginia Commonwealth University
Start
Apr 2017
Primary completion
May 2019
Modality
Cytokines & Interferons
01

Overview

A Phase 2 trial of anakinra in heart failure (HF), sponsored by Virginia Commonwealth University. Planned start Apr 2017; status: withdrawn.

02

Drugs

anakinra
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT03062176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03062176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call